Special Issue "Novel Formulations and Pharmaceutical Materials to Improve Therapeutic Outcomes for Patients. A Themed Issue Dedicated to Professor Ryan F. Donnelly"
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Special Issue Information
Prof. Ryan Donnelly is a Chair in Pharmaceutical Technology at the School of Pharmacy Queen’s University Belfast. His research is centered on design and physicochemical characterization of advanced polymeric drug delivery systems for transdermal and topical drug delivery, with a strong emphasis on improving therapeutic outcomes for patients. His work has covered a wide range of areas, such as medical/pharmaceutical materials, transdermal drug delivery, drug monitoring or photodynamic therapy, among others. Currently, Professor Donnelly's research is focused on novel polymeric microneedle arrays for transdermal administration of “difficult-to-deliver” drugs and intradermal delivery of vaccines and photosensitizers. He has authored over 600 peer-reviewed publications, including several granted patents, 5 textbooks, and approximately 160 full papers. He has been an invited speaker at numerous national and international conferences. Professor Donnelly is a Visiting Scientist at the Norwegian Institute for Cancer Research, where he is an Associate Member of the Radiation Biology Group. His work has attracted numerous awards, including the Controlled Release Society Young Investigator Award in 2016, BBSRC Innovator of the Year in 2013, the GSK Emerging Scientist Award in 2012, and the Royal Pharmaceutical Society Science Award in 2011. His contributions to the field are not only based on his actual research, as he teaches pharmaceutical technology and extemporaneous formulation to Pharmacy students. During his career, he has made a considerable and sustained contribution to the pharmaceutical sciences field, and accordingly, Molecules is highly pleased to host a Special Issue honoring Prof. Donnelly due to his outstanding achievements to develop new formulations to improve patient therapeutic outcomes.
Dr. Eneko Larrañeta
Dr. Aaron J. Courtenay
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Transdermal drug delivery
Intradermal drug delivery
|Period||1 Sep 2019 → …|
|Type of journal||Journal|
|Degree of Recognition||International|